Ectodomain Antibody Fused to Trimeric Form of Adenovirus Receptor B-2 Oncoprotein by Single-Chain erb Adenovirus Targeting to c-Updated Version
Ectodomain Antibody Fused to Trimeric Form of Adenovirus Receptor B-2 Oncoprotein by Single-Chain erb Adenovirus Targeting to c-Updated Version
复制标题
通过单链 erb 腺病毒靶向 c 更新版本,将胞外域抗体与腺病毒受体 B-2 癌蛋白三聚体融合
DOI:
--
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
I. Dmitriev
中科院分区:
文献类型:
--
作者:
E. Kashentseva;T. Seki;D. Curiel;I. Dmitriev
The use of adenovirus (Ad) vectors for cancer gene therapy applications is currently limited by several factors, including broad Ad tropism associated with the widespread expression of coxsackievirus and adenovirus receptor (CAR) in normal human tissues, as well as limited levels of CAR in tumor cells. To target Ad to relevant cell types, we have proposed using soluble CAR (sCAR) ectodomain fused with a ligand to block CARdependent native tropism and to simultaneously achieve infection through a novel receptor overexpressed in target cells. To confer Ad targeting capability on cancer cells expressing the c-erbB-2/HER-2/neu oncogene, we engineered a bispecific adapter protein, sCARfC6.5, that consisted of sCAR, phage T4 fibritin polypeptide, and C6.5 single-chain fragment variable (scFv) against c-erbB-2 oncoprotein. Incorporation of fibritin polypeptide provided trimerization of sCAR fusion proteins that, compared with monomeric sCAR protein, resulted in augmented affinity to Ad fiber knob domain and in increased ability to block CAR-dependent Ad infection. We demonstrated that sCARfC6.5 protein binds to cellular c-erbB-2 oncoprotein and mediates efficient Ad targeting via a CARindependent pathway. As illustrated in cancer cell lines that overexpress c-erbB-2, targeted Ad, complexed with sCARfC6.5 adapter protein, provided from 1.5to 17-fold enhancement of gene transfer compared with Ad alone and up to 130-fold increase in comparison with untargeted Ad complexed with sCARf control protein. The use of recombinant trimeric sCAR-scFv adapter proteins may augment Ad vector potency for targeting cancer cell types.
登录
查看更多内容
DOI:
--
发表时间:
1998-10
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Claudine Rancourt;Buck E. Rogers;B. Sosnowski;M. Wang;Alain Piché;G. Pierce;R. Alvarez;Gene P. Siegal;J. T. Douglas;David T. Curiel
通讯作者:
Claudine Rancourt;Buck E. Rogers;B. Sosnowski;M. Wang;Alain Piché;G. Pierce;R. Alvarez;Gene P. Siegal;J. T. Douglas;David T. Curiel
影响因子:
56.9
作者:
Bewley, MC;Springer, K;Flanagan, JM
通讯作者:
Flanagan, JM
影响因子:
5
作者:
Ando M;Nagata K;Nihira K;Suzuki Y;Kanda Y;Adachi M;Kubota T;Kameyama N;Nakano M;Ando H;Yamano K;Ishii T;Nakai R;Nakamura K
通讯作者:
Nakamura K
影响因子:
4
作者:
M. Hung;Y. Lau
通讯作者:
M. Hung;Y. Lau
影响因子:
11.2
作者:
Okegawa,T;Li,Y;Pong,RC;Bergelson,JM;Zhou,J;Hsieh,JT
通讯作者:
Hsieh,JT